A Phase IIb, Randomized, Double-Blind, Placebo Controlled Study for the Treatment of Active Celiac Disease With Larazotide Acetate (AT-1001)
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Larazotide (Primary)
- Indications Coeliac disease
- Focus Therapeutic Use
- Sponsors Alba Therapeutics
- 12 Dec 2014 New trial record